BlackRock Health Sciences Term Trust (NYSE:BMEZ) Portfolio Manager Purchases 18,052.30 in Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) Portfolio Manager Christopher Accettella purchased 1,190 shares of the stock in a transaction dated Thursday, January 11th. The stock was acquired at an average cost of 15.17 per share, for a total transaction of 18,052.30. Following the completion of the transaction, the portfolio manager now owns 4,070 shares of the company’s stock, valued at 61,741.90. The trade was a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

BlackRock Health Sciences Term Trust Price Performance

BMEZ opened at 15.89 on Friday. The business has a 50 day moving average of 15.85 and a 200-day moving average of 15.53. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th will be issued a dividend of $0.176 per share. This represents a $2.11 dividend on an annualized basis and a yield of 13.29%. The ex-dividend date is Tuesday, October 15th.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

A number of hedge funds have recently modified their holdings of the stock. Dakota Wealth Management boosted its stake in BlackRock Health Sciences Term Trust by 5.3% in the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after buying an additional 915 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 21.7% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock valued at $96,000 after acquiring an additional 1,038 shares during the period. Oppenheimer & Co. Inc. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 2.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock valued at $1,124,000 after acquiring an additional 1,536 shares during the period. Kingswood Wealth Advisors LLC boosted its stake in shares of BlackRock Health Sciences Term Trust by 9.2% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock valued at $360,000 after purchasing an additional 1,845 shares in the last quarter. Finally, Comerica Bank grew its holdings in shares of BlackRock Health Sciences Term Trust by 31.1% in the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after purchasing an additional 3,671 shares during the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.